SCHEMBL2669726

SCHEMBL2669726

CCO[PH](=O)Cc1cnc(NC(=O)c2cc(Oc3ccc(S(C)(=O)=O)cc3)cc(OC(C)C)c2)cn1

nearest known ligand 0.64

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GCK P35557 20/20 0.64
KCNH2 Q12809 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28079725 0.88 GCK (0.72) GCKKCNH2
SCHEMBL2659029 0.86 GCK (0.72) GCKKCNH2
SCHEMBL12021036 0.85 GCK (0.84) GCKKCNH2
SCHEMBL2658243 0.84 GCK (0.69) GCKKCNH2
SCHEMBL16676089 0.84 GCK (0.69) GCKKCNH2
Bromide SCHEMBL9983508 0.83 GCK (0.68) GCKKCNH2
SCHEMBL2669737 0.83 GCK (0.68) GCKKCNH2
Bromide SCHEMBL2659082 0.83 GCK (0.67) GCKKCNH2
SCHEMBL12021269 0.82 GCK (0.70) GCKKCNH2
SCHEMBL2661152 0.80 GCK (0.73) GCKKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009023718-A2 NOVEL ACTIVATORS OF GLUCOKINASE METABASIS THERAPEUTICS, INC. (US) 2009-02-19 WO disclosed